Similar Papers

Paper Title
Journal
Date
Author
CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signaling
Samantha M Fix ... Marie-Andrée Forget
Journal for ImmunoTherapy of Cancer | VOL. 10
Samantha M Fix, et. al.Samantha M Fix ... Marie-Andrée Forget
01 Jul 2022
Abstract 602: A novel TGF-β/IL-12R signal conversion platform that protects CAR T cells from TGF-β-mediated immune suppression and concurrently amplifies effector function
Benjamin Boyerinas ... Richard Morgan
Cancer Research | VOL. 77
Benjamin Boyerinas, et. al.Benjamin Boyerinas ... Richard Morgan
01 Jul 2017
Steroidogenesis-inducing protein interacts with transforming growth factor-β to stimulate DNA synthesis in rat granulosa cells
Shafiq A Khan ... Jennifer H Dorrington
Molecular and Cellular Endocrinology | VOL. 89
Shafiq A Khan, et. al.Shafiq A Khan ... Jennifer H Dorrington
01 Nov 1992
143 Mesothelin (MSLN) targeting allogeneic CAR T cells engineered to overcome tumor immunosuppressive microenvironment
Cecile Schiffer-Mannioui ... Valérie Guyot
Journal for ImmunoTherapy of Cancer | VOL. 9
Cecile Schiffer-Mannioui, et. al.Cecile Schiffer-Mannioui ... Valérie Guyot
01 Nov 2021
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry
Daniel J Landsburg ... Cameron J Turtle
Journal for ImmunoTherapy of Cancer | VOL. 13
Daniel J Landsburg, et. al.Daniel J Landsburg ... Cameron J Turtle
09 Feb 2025
Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma
Ramya Ramaswami ... Chia-Ching Jackie Wang
Journal for ImmunoTherapy of Cancer | VOL. 13
Ramya Ramaswami, et. al.Ramya Ramaswami ... Chia-Ching Jackie Wang
06 Feb 2025
Complete metabolic response as early predictor of long-term efficacy after adoptive T cell therapy using tumor-infiltrating lymphocytes
Troels Holz Borch ... Inge Marie Svane
Journal for ImmunoTherapy of Cancer | VOL. 13
Troels Holz Borch, et. al.Troels Holz Borch ... Inge Marie Svane
06 Feb 2025
Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study
Michiel M Smeenk ... Willemijn S M E Theelen
Journal for ImmunoTherapy of Cancer | VOL. 13
Michiel M Smeenk, et. al.Michiel M Smeenk ... Willemijn S M E Theelen
06 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.